• donor
  • The favored hypothesis is a depletion of patient and donor B cells reducing the presentation of minor histocompatibility alloantigens. (knowcancer.com)
  • treatment
  • Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma. (nih.gov)
  • immune
  • To obtain information about the effects of interferon-gamma and aldesleukin on the number, function, and activation state of immune effector-cells including T-cells and B-cells. (knowcancer.com)